UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析

◆英語タイトル:UMN Pharma Inc (4585) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139967FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UMN Pharma Inc (UMN Pharma), a subsidiary of Shionogi Inc, is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s pipeline products include UMN-101 for the treatment of Recombinant seasonal influenza vaccine; UMN-102 for recombinant novel influenza vaccine; UMN-103 for recombinant rotavirus vaccine; and UMN-104 for Recombinant norovirus vaccine. It also partners with universities and pharmaceutical companies for biosimilars business and biopharmaceuticals manufacturing, among others. UMN Pharma is headquartered in Yokohama, Japan.

This comprehensive SWOT profile of UMN Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of UMN Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

UMN Pharma Inc – Key Information
UMN Pharma Inc – Overview
UMN Pharma Inc – Key Employees
UMN Pharma Inc – Key Employee Biographies
UMN Pharma Inc – Key Operational Heads
UMN Pharma Inc – Major Products and Services
UMN Pharma Inc – History
UMN Pharma Inc – Company Statement
UMN Pharma Inc – Locations And Subsidiaries
UMN Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

UMN Pharma Inc – Business Description
UMN Pharma Inc – Corporate Strategy
UMN Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
UMN Pharma Inc – Strengths
UMN Pharma Inc – Weaknesses
UMN Pharma Inc – Opportunities
UMN Pharma Inc – Threats
UMN Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

UMN Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

UMN Pharma Inc, Key Information
UMN Pharma Inc, Key Ratios
UMN Pharma Inc, Share Data
UMN Pharma Inc, Major Products and Services
UMN Pharma Inc, History
UMN Pharma Inc, Key Employees
UMN Pharma Inc, Key Employee Biographies
UMN Pharma Inc, Key Operational Heads
UMN Pharma Inc, Other Locations
UMN Pharma Inc, Subsidiaries
UMN Pharma Inc, Key Competitors
UMN Pharma Inc, SWOT Analysis
UMN Pharma Inc, Ratios based on current share price
UMN Pharma Inc, Annual Ratios
UMN Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Copper Mountain Mining Corporation:企業の戦略・SWOT・財務情報
    Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Otsuka Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Qurate Retail, Inc.:企業の戦略・SWOT・財務情報
    Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report Summary Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Wistar Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biolo …
  • Dassault Systemes SE (DSY):企業の財務・戦略的SWOT分析
    Dassault Systemes SE (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TOP Ships Inc (TOPS):石油・ガス:M&Aディール及び事業提携情報
    Summary TOP Ships Inc (Top Ships), formerly known as Top Tankers Inc., is a provider of international seaborne transportation services. It owns and operates eco medium range (MR) tanker vessels focusing on the transportation of petroleum products, crude oil and bulk liquid chemicals. The company ser …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • KrisEnergy Holdings Ltd (SK3):企業の財務・戦略的SWOT分析
    Summary KrisEnergy Holdings Ltd (KrisEnergy) is an independent upstream company that production and development of oil and gas in the basins. The company discovers, appraises, develops and produces hydrocarbon resources. It services comprise development and production of identifying potential prospe …
  • Strides Shasun Limited:企業のM&A・事業提携・投資動向
    Strides Shasun Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strides Shasun Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Asterand Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asterand Bioscience Inc (Asterand) is a biopharmaceutical company that offers tissue based products and contract research services. The company offers human tissue and human tissue-based research solutions to drug discovery scientists. Its products include biospecimens, human tissue and biof …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • Netcare Ltd (NTC):企業の財務・戦略的SWOT分析
    Summary Netcare Ltd (Netcare) is a healthcare service provider that offers patient care services. The center provides medical facilities and treatments in the fields of breast care, oncology, orthopedics, renal care, transplants and weight management. Its facilities include medicross centers, netcar …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務分析
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Therapure Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therapure Biopharma Inc (Therapure) is a biotherapeutics company that enhances patient care through its three divisions: therapure biomanufacturing, therapure innovations and evolve biologics. The company's therapure biomanufacturing division offers pipeline products such as TBI 301, TBI 302 …
  • Lakeland Bancorp, Inc.:企業の戦略・SWOT・財務情報
    Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Becton, Dickinson:戦略・SWOT・企業財務分析
    Becton, Dickinson - Strategy, SWOT and Corporate Finance Report Summary Becton, Dickinson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • F-star Biotechnology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆